Skip to main content
NeuPath Health Inc. logo

NeuPath Health Inc. — Investor Relations & Filings

Ticker · NPTH ISIN · CA64133P1009 TSXV Human health and social work activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2026-05-14 Management Reports
Country CA Canada
Listing TSXV NPTH

About NeuPath Health Inc.

https://neupath.com/

NeuPath Health Inc. is an integrated healthcare provider specializing in chronic pain management and musculoskeletal (MSK) care. The company operates a network of clinics offering comprehensive assessments and rehabilitation services. NeuPath utilizes a vertically integrated, interdisciplinary approach, leveraging research, data-driven insights, and technology to develop patient-centered, tailored treatment plans. Services address a range of conditions including acute and chronic pain, spinal injuries, sports-related injuries, and concussions. The company is also noted for providing innovative treatments, such as Arthrosamid, for conditions like knee osteoarthritis.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Management Reports Classification · 92% confidence The document is titled "Management's Discussion and Analysis (MD&A)" and provides management’s commentary on the company’s interim results, operations, and non-GAAP measures for the quarter ended March 31, 2026. It does not include the full audited annual report (10-K) nor is it merely an announcement; rather, it is a substantive management explanation of financial results and trends. This aligns with the definition of a Management Report (Code: MDA).
2026-05-14 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 98% confidence The document contains the full condensed consolidated interim financial statements of NeuPath Health Inc. for the three months ended March 31, 2026 and 2025, including balance sheet, income statement, cash flows, changes in equity, and notes. It is unaudited but fully substantive with actual financial data for a quarter. This matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 English
News release - English.pdf
Earnings Release Classification · 93% confidence The document is a press release announcing NeuPath Health’s first quarter 2026 financial and operating results, including key revenue and EBITDA metrics, quarter-over-quarter comparisons, a summary of highlights, and details of an upcoming investor webinar. It does not contain the full interim financial statements or MD&A itself (those are referenced as available elsewhere). This fits the definition of an Earnings Release (initial announcement of quarterly/periodical financial results). Q1 2026
2026-05-14 English
Notice of meeting - English.pdf
Regulatory Filings
2026-05-08 English
News release - English.pdf
Regulatory Filings
2026-05-05 English
News release - English.pdf
Regulatory Filings Classification · 23% confidence The document is a press release announcing NeuPath Health’s CEO will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference. It does not contain actual financial results, slide decks, an earnings summary, nor detailed presentation materials. It is simply a corporate announcement of an upcoming investor event. This does not fit into categories like 10-K, IR, ER, IP (actual presentation), or PSI. Therefore, the best fit is the general “Regulatory Filings” fallback category (RNS).
2026-04-09 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.